Additional file 4 of Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma

Additional file 4: Table S3. Raw data from TERTp C228T and C250T sequencing with 113bp and 88bp assays per patient in the entire cohort.

补充文件4：表S3。全部队列中每例患者采用113bp与88bp检测体系对TERTp（telomerase reverse transcriptase promoter）C228T及C250T位点进行测序的原始数据。